SERPINA1 and hepatocellular carcinoma: Increased levels of serum A1AT in HCC patients are in correlation with shorter survival, and a difference of serum A1AT of 0.02 g/L correlates with 25% shorter expected survival time , while a difference of 0.04 g/L implies more than 40% decrease in survival time (68).